Laura E. Gressler
Assistant Professor
Also affiliated: University of Maryland, Baltimore (2018–2021); United States Food and Drug Administration (2021–2024); Center for Devices and Radiological Health (2021–2023); University of Arkansas Medical Center (2023–2024); Health Services Research & Development (2017); Central Arkansas Veterans Healthcare System (2017); University of Maryland, College Park (2020–2021)
COP | Pharmaceutical Evaluation & Policy
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Laura E. Gressler's research investigates patterns of opioid and benzodiazepine use, focusing on adverse outcomes and risk factors within specific populations, including US veterans and pregnant women. Her work has examined the association of criminal statutes for opioid use disorder with treatment prevalence among pregnant individuals and the factors influencing opioid initiation in veterans with traumatic brain injury. Gressler also studies patient motivations for substance use disorder treatment and consumer willingness to pay for pharmacy services. She has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Danica Marinac‐Dabic, Ambrish A. Pandit, Corey J. Hayes, and Kanna Lewis, contributing to a shared publication record.
Metrics
- h-index: 11
- Publications: 84
- Citations: 451
Positions
-
Assistant Professor 2021–presentUniversity of Arkansas for Medical Sciences COP | Pharmaceutical Evaluation & Policy Institutional directory
Selected Publications
-
State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023 (2026)
-
Contraceptive Access for Active Duty Service Women: Evaluation of Women and Infant Community Care Clinics in the Military Health System (2026)
-
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part III— Questions for Translational Science and Action Theory (2025)
-
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part I—Coordinated Registry Networks and Systemic Coordinated Inter-Organizational Networks (2025)
-
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II—How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks (2025)
-
Temporomandibular Disorders at a Crossroads: Meeting Summary (2025)
-
OP25 Understanding the Needs and Aspirations of Emerging HEOR Talent: Results From the ISPOR New Professional and Student Survey (2025)
-
The role of manufacturer and user facility database in evaluating BPH and prostate cancer procedures (2025)
-
Regulatory Challenges and Opportunities: A Review of U.S. Food and Drug Administration-Approved Artificial Intelligence and Machine Learning-Enabled Cardiovascular Devices (2025)
-
Contraceptive Prescribing and Dispensing After the Defense Health Agency’s Policy Change (2025)
-
Sustainable, Cooperative, Inclusive, Organized Networks, and Translational Health: A Book Review of Saving Societies from Within: Innovation and Equity through Inter-Organizational Networks (2025)
-
Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics (2025)
-
HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis (2025)
-
Changes in maternal morbidity and infant outcomes following state-level abortion bans post-Dobbs: a comparative interrupted time series study (2025)
-
Generation of Risk Score for Serious Non-Steroidal Anti-Inflammatory Drug (NSAID) Induced Cardiovascular Events (NAÏVE) Among Active-Duty Service Members and Veterans (2025)
Grants & Funding
As listed on this researcher's institutional profile.
- Contraceptive Care among Active-Duty Service Women US Department of Defense via Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Principal Investigator
Collaboration Network
Top Collaborators
- A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks
- Development of a core minimum data set to advance real-world evidence generation for uterine fibroids treatment technologies
- Venous Access: National Guideline and Registry Development (VANGUARD): Advancing Patient-Centered Venous Access Care Through the Development of a National Coordinated Registry Network
- Developing the foundation for assessment of Devices used for Acute Ischemic Stroke Interventions (DAISI) using a Coordinated Registry Network
- Building Blocks for the Long-acting and Permanent Contraceptives Coordinated Registry Network
Showing 5 of 13 shared publications
- Identifying Risk Factors for Cardiovascular Events Among Active-Duty Service Members and Veterans Prescribed Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Development and Testing of a Chronic-Disease Patient Experience Mapping Toolbox
- Naloxone Prescribing Associated With Reduced Emergency Department Visits in the Military Health System
- Benzonatate Safety and Effectiveness: A Systematic Review of the Literature
- Medication Trends in the Military: A Comparative Analysis of Prescribing Patterns Among Service Members Seen by a Pharmacist and Implications for Medical Readiness
Showing 5 of 9 shared publications
- National Long-Term Trends in Postoperative Opioid Prescribing in Ambulatory Urology Procedures
- Evaluation of proudP
- CO148 Opioid Prescribing Among Commercially Insured Men Undergoing a Procedure for the Treatment Benign Prostatic Hyperplasia
- Opioid prescribing patterns following surgical interventions for benign prostatic hyperplasia
- Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics
Showing 5 of 6 shared publications
- National Long-Term Trends in Postoperative Opioid Prescribing in Ambulatory Urology Procedures
- Evaluation of proudP
- CO148 Opioid Prescribing Among Commercially Insured Men Undergoing a Procedure for the Treatment Benign Prostatic Hyperplasia
- Opioid prescribing patterns following surgical interventions for benign prostatic hyperplasia
- Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics
Showing 5 of 6 shared publications
- Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study
- Racial/Ethnic Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
- Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study
- HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
Showing 5 of 6 shared publications
- Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans
- Consumer willingness to pay for pharmacy services: An updated review of the literature
- Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury
- Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research
- State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023
- Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans
- Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
- State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023
- Venous Access: National Guideline and Registry Development (VANGUARD): Advancing Patient-Centered Venous Access Care Through the Development of a National Coordinated Registry Network
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II—How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part I—Coordinated Registry Networks and Systemic Coordinated Inter-Organizational Networks
- Venous Access: National Guideline and Registry Development (VANGUARD): Advancing Patient-Centered Venous Access Care Through the Development of a National Coordinated Registry Network (Preprint)
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part III— Questions for Translational Science and Action Theory
- Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study
- Racial/Ethnic Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
- PCR120 Association of Race/Ethnicity and Patient Care Experiences with Receipt of Definitive Treatment Among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study
- Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study
- Racial/Ethnic Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
- PCR120 Association of Race/Ethnicity and Patient Care Experiences with Receipt of Definitive Treatment Among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study
- Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study
- Racial/Ethnic Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study
- PCR120 Association of Race/Ethnicity and Patient Care Experiences with Receipt of Definitive Treatment Among Prostate Cancer Survivors: A SEER-CAHPS Study
- Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study
- Development of a core minimum data set to advance real-world evidence generation for uterine fibroids treatment technologies
- Developing the foundation for assessment of Devices used for Acute Ischemic Stroke Interventions (DAISI) using a Coordinated Registry Network
- Building Blocks for the Long-acting and Permanent Contraceptives Coordinated Registry Network
- Building the foundation for a modern patient-partnered infrastructure to study temporomandibular disorders
- Orthopedic Coordinated Registry Network (Ortho-CRN): advanced infrastructure for real-world evidence generation
- A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II—How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part I—Coordinated Registry Networks and Systemic Coordinated Inter-Organizational Networks
- RWD139 Enhancing Public Health Through Timely Detection: Assessing the Value of Real-World Evidence With a Cardiovascular Defibrillator Leads Case Study
- Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part III— Questions for Translational Science and Action Theory
- National Long-Term Trends in Postoperative Opioid Prescribing in Ambulatory Urology Procedures
- Evaluation of proudP
- Opioid prescribing patterns following surgical interventions for benign prostatic hyperplasia
- Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics
- The role of manufacturer and user facility database in evaluating BPH and prostate cancer procedures
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration
- HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
- State X-waiver Statutes and Buprenorphine Prescriber Rates Following Federal X-waiver Elimination, 2021–2023
Similar Researchers
Based on overlapping research topics